GLOBAL BIOPHARMACEUTICALS MARKET :Global Demand Analysis & Opportunity Outlook 2022 :Top keyplayers are Pfizer, Inc., F. Hoffmann-La Roche AG., Johnson & Johnson Services, Inc., Sanofi, Amgen Inc., Bayer AG

Kenneth research - Monday, February 11, 2019.
Enviado por Peter Jackson

Description

Biopharmaceuticals are medical drugs produced using biotechnology. Unlike the conventional pharmaceutical which is a chemical synthesis, biopharmaceuticals are proteins or nucleic acids that are produced by means other than direct extraction from a native biological source. The biopharmaceutical industry is a sunshine industry, radically new concepts are making to the market, such as cell therapy Provenge, which is used to treat cancer, and gene therapies which offer the promise of regenerative medicine and disease remission. Investing in biotech R&D has yielded better returns than the pharmaceutical industry average. The number of biotechnology patents applied for every year has been growing at 25 percent annually since 1995. Enhanced efficacy and low side effect has led to the growing preference of biopharmaceuticals over conventional pharmaceuticals.

 

Request For Free Sample@ https://www.kennethresearch.com/sample-request-10064884  


Market Dynamics


The biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharmaceuticals market. It is the fastest growing part of the pharmaceutical industry with annual growth of more than 8 percent, double that of conventional pharmaceuticals. Their ability to address previously untreatable conditions allows companies to command high prices for the drugs. Strong demand has driven significant profits, despite the high cost of goods sold.
The transition of biopharmaceuticals from the laboratory to market is paved with challenges of maintaining competitiveness by ensuring affordability, quality, and delivery performance. There are also operational and technical challenges, as reproducing large molecules reliably at an industrial scale requires manufacturing capabilities of high sophistication.
In the coming years, disruptive innovation such as immunotherapy, antibody drug conjugates, and gene and cell therapy will make progress toward commercial launch.


Market Segmentation


The biopharmaceutical market can be segmented on product basis -gene and cell therapy, cytokines, PEH (proteins, enzymes, hormones), monoclonal antibodies, vaccines, blood and allergenic components, and other.


Regional/Geographic Analysis


The United States accounts for nearly half of the global sales of biopharmaceuticals. The United States also accounts for more than 50 percent of investment in research and development in biopharmaceuticals. In recent years, countries like India and China have become favored destinations for biopharmaceuticals. With increase in affordability, the biopharmaceutical market will expand as there will be demand from Asia and Africa.


Key Players


Pfizer, Inc., F. Hoffmann-La Roche AG., Johnson & Johnson Services, Inc., Sanofi, Amgen Inc., Bayer AG.

 

Buy Now@ https://www.kennethresearch.com/report-purchase-id-10064884  


Report Contents Regional Analysis Report Highlights


Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market - Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada

Latin America
Mexico, Brazil, Argentina and Rest of Latin America

Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe

Eastern Europe
Russia
Poland
Rest of Eastern Europe

Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific

Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

 

Read More@ https://www.kennethresearch.com/report-details/global-biopharmaceuticals-market/10064884


Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage

 

Contact Us

 

Name:  David

Email : Sales@kennethresearch.com

Phone: +1 313 462 0609

Acerca de Kenneth research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Mas información acerca de Kenneth research

  • Imprimir
  • Reportar abuso

Comentarios

Escribe tu comentario